背景有基因1型丙型肝炎病毒（HCV）感染，但对聚乙二醇干扰素α和利巴韦林疗法没有持续应答的病人，复治成功的可能性低。
Background Patients with genotype 1 hepatitis C virus (HCV) who do not have a sustained response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment.
还有个原因，在中国基本保险只支付聚乙二醇干扰素α-2a和50毫克的聚乙二醇干扰素α-2b。
The other factor in China is that the basic assistance covers for pegylated interferon alpha-2a and for 50mg of pegylated interferon alpha-2b.
还有个原因，在中国基本保险只支付聚乙二醇干扰素α-2a和50毫克的聚乙二醇干扰素α-2b。
The other factor in China is that the basic assistance covers for pegylated interferon alpha-2a and for 50mg of pegylated interferon alpha-2b.
应用推荐